J&J To Pay $1B To Settle Risperdal Civil Claims: Report
Johnson & Johnson will reportedly pay more than $1 billion to settle civil claims made by the federal government and several states that it illegally marketed the antipsychotic drug Risperdal....To view the full article, register now.
Already a subscriber? Click here to view full article